Evidence mapPaperPMID 42487657Full record

ArticleClinical case reports2026

Tardive Dyskinesia Induced by Long-Acting Injectable Paliperidone Palmitate Once Every 3 Months in a Patient With Schizophrenia: A Case Report and Literature Review.

Jianmiao Ge, Jing Li, Ruiting Ma, Lijun Tong, Qijing Bo, Zhiyang Zhang

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianmiao GeBeijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders, National Clinical Research Center for Mental Disorders; National Center for Mental Disorders Beijing Anding Hospital, Capital Medical University Beijing China.ORCID https://orcid.org/0009-0006-6739-4886
Jing LiBeijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders, National Clinical Research Center for Mental Disorders; National Center for Mental Disorders Beijing Anding Hospital, Capital Medical University Beijing China.
Ruiting MaInner Mongolia Autonomous Region Mental Health Center Hohhot China.
Lijun TongInner Mongolia Autonomous Region Mental Health Center Hohhot China.
Qijing BoBeijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders, National Clinical Research Center for Mental Disorders; National Center for Mental Disorders Beijing Anding Hospital, Capital Medical University Beijing China.
Zhiyang ZhangBeijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders, National Clinical Research Center for Mental Disorders; National Center for Mental Disorders Beijing Anding Hospital, Capital Medical University Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prolonged use of long-acting injectable antipsychotics may lead to tardive dyskinesia (TD). Clinicians should regularly assess the risk of TD. They should promptly discontinue the long-acting medication, switch to an antipsychotic with a low risk of TD, and initiate supportive care as soon as signs of TD appear.

Indexed as

antipsychotic drugslong‐acting injectablePaliperidone injectionschizophreniatardive dyskinesia

Identifiers

PMID42487657
PMCPMC13390019

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.